Expert in biopharmaceuticals

Specialising in biopharmaceuticals, the LFB group is one of the few pharmaceutical companies in the world to master a range of advanced bioproduction techniques.

From an expertise in plasma-derived medicinal products, LFB has developed its technological capabilities, positioning our business in promising areas of 21st century healthcare: recombinant medicines – including monoclonal antibodies.


Recombinant medicines

The LFB group develops and manufactures recombinant proteins
and monoclonal antibodies using both our EMABling® and rPRO
technology platforms.